Question 1

Does RhumbLine Advisers own CNST stock?

Accepted Answer

As of its Q2 2021 13F, RhumbLine Advisers held 52,829 shares of CNST (Constellation Pharmaceutical), worth $1.8M.

Question 2

How many shares of CNST does RhumbLine Advisers own?

Accepted Answer

As of its Q2 2021 13F, RhumbLine Advisers held 52,829 shares of CNST (Constellation Pharmaceutical).

Question 3

What is RhumbLine Advisers' CNST position worth?

Accepted Answer

As of its Q2 2021 13F, RhumbLine Advisers' CNST position was worth $1.8M.

Question 4

When did RhumbLine Advisers first buy CNST?

Accepted Answer

RhumbLine Advisers first reported CNST in its Q1 2019 13F and listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Increased	52,829	+49.3%	$1.8M	0.0%	—	36
2021-Q1	Decreased	35,394	-8.2%	$828,000	0.0%	—	0
2020-Q4	Increased	38,550	+6.8%	$1.1M	0.0%	—	27
2020-Q3	Decreased	36,096	-10.5%	$731,000	0.0%	—	0
2020-Q2	Increased	40,331	+68.2%	$1.2M	0.0%	—	37
2020-Q1	Increased	23,974	+17.9%	$754,000	0.0%	—	29
2019-Q4	Increased	20,331	+2.4%	$958,000	0.0%	—	26
2019-Q3	Increased	19,860	+0.2%	$128,000	0.0%	—	22
2019-Q2	Increased	19,824	+21.5%	$243,000	0.0%	—	28
2019-Q1	New	16,312	-	$221,000	0.0%	—	32

CNST11 quarters

CNST
11 quarters